• 1
    Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med 2000; 342: 19608.
  • 2
    Gustin DM, Brenner DE. Chemoprevention of colon cancer: current status and future prospects. Cancer Metastasis Rev 2002; 21: 32348.
  • 3
    Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982; 23: 83542.
  • 4
    Schulmann K, Reiser M, Schmiegel W. Colonic cancer and polyps. Best Pract Res Clin Gastroenterol 2002; 16: 91114.
  • 5
    Halliwell B, Zhao K, Whiteman M. The gastrointestinal tract: a major site of antioxidant action? Free Radic Res 2000; 33: 81930.
  • 6
    Thomson A, Hemphill D, Jeejeebhoy KN. Oxidative stress and antioxidants in intestinal disease. Dig Dis 1998; 16: 1528.
  • 7
    Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A 1995; 92: 525865.
  • 8
    Sies H. Oxidative Stress: Introductory remarks. In: SiesH, ed. Oxidative Stress. Orlando, USA: Academic Press, 1985: 17.
  • 9
    Maxwell SRJ. Antioxidant vitamin supplements update of their potential benefits and possible risks. Drug Saf 1999; 21: 25366.
  • 10
    Diplock AT. Antioxidants and disease prevention. Mol Aspects Med 1994; 15: 293376.
  • 11
    Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis 2000; 21: 52530.
  • 12
    Turini ME, DuBois RN. Primary prevention: phytoprevention and chemoprevention of colorectal cancer. Hematol Oncol Clin North Am 2002; 16: 81140.
  • 13
    Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N Engl J Med 2000; 342: 115662.
  • 14
    Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med 1998; 129: 51724.
  • 15
    Meyer F, White E. Alcohol and nutrients in relation to colon cancer in middleaged adults. Am J Epidemiol 1993; 138: 22536.
  • 16
    Michels KB, Giovannucci E, Joshipura KJ, et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 2000; 92: 174052.
  • 17
    Gwyn K, Sinicrope FA. Chemoprevention of colorectal cancer. Am J Gastroenterol 2002; 97: 1321.
    Direct Link:
  • 18
    Salganik RI. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001; 20 (Suppl.): 464S72S.
  • 19
    Lopaczynski W, Zeisel SH. Antioxidants, programmed cell death, and cancer. Nutr Res 2001; 21: 295307.
  • 20
    Higgins JPT, Green S. (eds) Cochrane handbook for systematic reviews of interventions 4.2.5 (updated May 2005). In: The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons Ltd, 2005.
  • 21
    McAlister FA, Straus SE, Sackett DL, Altman DG. Analysis and reporting of factorial trials: a systematic review. JAMA 2003; 289: 254553.
  • 22
    Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. Int J Technol Assess Health Care 2003; 19: 591603.
  • 23
    Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analysis. Lancet 1998; 352: 60913.
  • 24
    Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 40812.
  • 25
    Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135: 9829.
  • 26
    Als-Nielsen B, Gluud LL, Gluud C. Methodological Quality and Treatment Effects in Randomised Trials – a Review of six Empirical Studies (abstract). In: Program & Abstract Book. 12th Cochrane Colloquium, Ottawa, Canada, 2004; October 2-6: 88–9.
  • 27
    DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987; 6: 34150.
  • 28
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 29
    Sharp SJ. Meta-analysis regression. Stata Tech Bull 1998; 42: 1622.
  • 30
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 153958.
  • 31
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088101.
  • 32
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 62934.
  • 33
    McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 1988; 48: 47015.
  • 34
    Roncucci L, Di Donato P, Carati L, et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16. Dis Colon Rectum 1993; 36: 22734.
  • 35
    Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 1994; 331: 1417.
  • 36
    MacLennan R, Macrae F, Bain C, et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J Natl Cancer Inst 1995; 87: 17606.
  • 37
    Ponz de Leon M, Roncucci L. Chemoprevention of colorectal tumors: role of lactulose and of other agents. Scand J Gastroenterol 1997; 222: 725.
  • 38
    Bonelli L, Camoriano A, Ravelli P, Missale G, Bruzzi P, Aste H. Reduction of the incidence of metachronous adenomas of the large bowel by means of antioxidants. In: PalmieriY, ed. Proceedings of International Selenium Tellurium Development Association. Brussels, Belgium: Se-Te Press, 1998: 9194.
  • 39
    Hofstad B, Almendingen K, Vatn M, et al. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 1998; 59: 14856.
  • 40
    Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev 1999; 8: 48993.
  • 41
    Jass JR, Sobin LH. Histological Typing of Intestinal Tumors. WHO International Histological Classification of Tumours. Berlin, Germany: Springer-Verlag, 1989.
  • 42
    Anonymous. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 102935.
  • 43
    Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004; 364: 121928.
  • 44
    Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Institute of Medicine. Dietary Reference intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC, USA: National Academy Press, 2000: 1800.
  • 45
    Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC, USA: National Academy Press, 2000: 1529.
  • 46
    Draper HH, Bird RP. Micronutrients and cancer prevention: are the RDAs adequate? Free Radic Biol Med 1987; 3: 2037.
  • 47
    Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 3746.
  • 48
    Paolini M, Abdel-Rahman SZ, Sapone A, et al. Beta-carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat Res 2003; 7719: 16.
  • 49
    Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 11505.
  • 50
    Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998; 392: 559.
  • 51
    Lee SH, Oe T, Blair IA. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 2001; 292: 20836.
  • 52
    Connelly AE, Satia-Abouta J, Martin CF, et al. Vitamin C intake and apoptosis in normal rectal epithelium. Cancer Epidemiol Biomarkers Prev 2003; 12: 55965.
  • 53
    Butler LM, Hewett PJ, Fitridge RA, Cowled PA. Deregulation of apoptosis in colorectal carcinoma: theoretical and therapeutic implications. Aust N Z J Surg 1999; 69: 8894.
  • 54
    Albanes D, Malila N, Taylor PR, et al. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control 2000; 11: 197205.
  • 55
    Early DS, Hill K, Burk R, Palmer I. Selenoprotein levels in patients with colorectal adenomas and cancer. Am J Gastroenterol 2002; 97: 7458.
    Direct Link:
  • 56
    Al-Taie OH, Seufert J, Karvar S, et al. Selenium supplementation enhances low selenium levels and stimulates glutathione peroxidase activity in peripheral blood and distal colon mucosa in past and present carriers of colon adenomas. Nutr Cancer 2003; 46: 12530.
  • 57
    Jacobs ET, Jiang R, Alberts DS, et al. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst 2004; 96: 166975.
  • 58
    Reid ME, Duffield-Lillico AJ, Sunga A, Fakih M, Alberts DS, Marshall JR. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer 2006; 118: 177781.
  • 59
    Kelloff GJ, Schilsky RL, Alberts DS, et al. Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs. Clin Cancer Res 2004; 10: 390818.
  • 60
    Kelloff GJ, Bast RC Jr, Coffey DS, et al. Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue. Clin Cancer Res 2004; 10: 38814.
  • 61
    Levin B. Potential pitfalls in the use of surrogate endpoints in colorectal adenoma chemoprevention. J Natl Cancer Inst 2003; 95: 6979.
  • 62
    Jass JR. Limitations of the adenoma-carcinoma sequence in colorectum. Clin Cancer Res 2004; 10: 596970.
  • 63
    McKevith B, Kelly C, Stanner S, Hughes J, Buttriss J. The Food Standards Agency's antioxidants in food programme – a summary. J Hum Nutr Diet 2003; 16: 25763.
  • 64
    Buttriss JL, Hughes J, Kelly CNM, Stanner S. Antioxidants in food: a summary of the review conducted for the Food Standards Agency. Nutr Bull 2002; 27: 22736.
  • 65
    Ritenbaugh C, Streit K, Helfand M. Routine Vitamin Supplementation to Prevent Cancer: Summary of Evidence from Randomized Controlled Trials. Available at:, accessed on 10 October 2005.
  • 66
    Atkins D, Shetty P. Update of the Evidence from Randomized Controlled Trials, 1999–2002. Routine Vitamin Supplementation to Prevent Cancer. Available at:, accessed on 10 October 2005.
  • 67
    Stanner SA, Hughes J, Kelly CN, Buttriss J. A review of the epidemiological evidence for the ‘antioxidant hypothesis’. Public Health Nutr 2004; 7: 40722.
  • 68
    Bast A, Haenen GRMM. The toxicity of antioxidants and their metabolites. Environ Toxicol Pharmacol 2002; 11: 2518.